A subgroup of patients with HBeAg-negative chronic hepatitis B virus (HBV) infection who ceased their long-term nucleotide analogue treatment maintained virological suppression, pointing to a group of patients who may be suitable for treatment cessation, according to a recent study.
Sorafenib, in combination with conventional transarterial chemoembolization (cTACE), does not significantly improve overall survival (OS) in hepatocellular carcinoma (HCC) patients, relative to sorafenib alone, a recent study has found.
Taking curcumin daily in addition to losing weight does not exert a superior effect on cardiovascular (CV) risk factors in patients with nonalcoholic fatty liver disease (NAFLD) when compared with losing weight alone, according to a study.
Women with a high body mass index (BMI) early in life are at heightened risk of developing severe liver disease later in life, and obesity is associated with the greatest risk, as reported in a recent study.
Prevalence of hepatitis C virus (HCV) infection has decreased in both the blood donor (BD) and haemodialysis (HD) populations but remains high in the intravenous drug user (IVDU) population, a Singapore study has found.
Mycophenolate mofetil is well tolerated and highly effective in the second-line treatment of patients with autoimmune hepatitis (AIH), although response is greater in those who initiated treatment due to intolerance to standard therapy than in those with nonresponse, according to a systematic review and meta-analysis.